Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 372,000 shares, a drop of 10.3% from the April 30th total of 414,500 shares. Based on an average daily volume of 185,300 shares, […]
HC Wainwright restated their buy rating on shares of Werewolf Therapeutics (NASDAQ:HOWL – Free Report) in a research report released on Friday morning, Benzinga reports. The firm currently has a $15.00 price objective on the stock. Other equities analysts have also recently issued research reports about the stock. Wedbush reiterated an outperform rating and issued […]
Werewolf Therapeutics (NASDAQ:HOWL) Stock Rating Reaffirmed by HC Wainwright wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Werewolf Therapeutics (NASDAQ:HOWL – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Wedbush in a research report issued on Monday, RTT News reports. They presently have a $9.00 target price on the stock. Wedbush’s target price points to a potential upside of 50.50% from the company’s previous close. Other equities […]
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 318,400 shares, a growth of 562.0% from the October 15th total of 48,100 shares. Based on an average trading volume of 809,800 shares, the short-interest ratio […]